The effect of halothane, enflurane and isoflurane on the circulation by Coetzee, A. R. et al.
SAMT VOL 76 21 OKT 1989 417
The effect of halothane, enflurane and isoflurane
on the circulation
A. R. COETZEE, P. R. FOURIE, E. BADENHORST
Summary
This study, in open-chested dogs, sought to explore the
relationship between whole-body oxygen delivery and oxygen
consumption during anaesthesia, using increasing concen-
trations of halothane, enflurane and isoflurane. Results indi-
cate that the cardiac index and oxygen delivery became
critical at less than 1 MAC (minimal alveolar concentration of
anaesthetic) for the three commonly used vapours. Halothane
caused the least depression of contractility, but the stroke
volume was reduced by the well-maintained afterload at 1
MAC. Enflurane and isoflurane were associated with more
depression of contractility, but the cardiac output was main-
tained by an increase in heart rate in the case 01 isoflurane
and reduced mean arterial pressure during the use of
enllurane.
S Atr Med J 1989; 76: 417-421.
Myocardial contractility represents the potential of the heart
to do work under a given set of circumstances. However, the
expression of this potential is modified by the heart rate (HR)
afterload and preload. The anaesthesiologist is concerned with
the maintenance of cellular oxygenation, and cardiac output
(CO) therefore justifies more of his attention than myocardial
contractility per se.
This study was undenaken to elucidate the effect of halo-
thane, enflurane and isoflurane on myocardial contractility and
the function of the heart as a pump with specific reference to
the maintenance of cellular oxygenation.
Materials and methods
The study was approved by the Ethics Committee of the
University of Stellenbosch Medical School and care of the
animals was in accordance with national and institutional
guidelines.
Thirty mongrel dogs, mean weight 24,7 kg (range 20,5 -29,2
kg), were used. Each anaesthetic agent was evaluated in 10
animals.
The animals were premedicated with intramuscular mor-
phine !,5 mg/kg and anaesthesia was induced with intravenous
fentanyl 15 JIglkg and thiopentone 15 mg/kg. After endo-
tracheal intubation the animals were mechanically ventilated
with 40% oxygen and 60% nitrogen (fresh gas flow 3 l/min).
The tidal volume was adjusted to maintain the partial arterial
carbon dioxide pressure (PaC02) between 4,6 and 5,2 kPa. The
anaesthetic gases were vaporised from calibrated vaporisers
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(halothane: Dragerwerk, Germany; enflurane and isoflurane:
Cyprane, UK) and the end-tidal concentrations of the anaes-
thetic gases were monitored (Normae; Datex, Finland).
Normal saline was infused at a rate of 5 ml/kg/h and
fentanyl 7 JIglkglh was added to the infusion.
Temperature, which was monitored from the thermistor at
the tip of the pulmonary artery catheter, was maintained
between 36,5 and 37,3°C with the aid of an under-table
heating system.
Through an incision in the neck a cannula was positioned in
the aona via the internal carotid anery and connected to a
pressure transducer (Statham P23; Statham, Hato Rey -
natural frequency 50,3 Hz). This was used to monitor blood
pressure. A 7F pulmonary anery (PA) catheter (Edwards
Laboratories, USA) was floated into the proximal PA. Five
per cent dextrose at O°C was manually injected into the PA
catheter for the determination of CO by the thermodilution
method (Mansfield 9530 Cardiac Output Computer, USA).
The mean of three values is reponed.
A left thoracotomy was performed and the hean suspended
in a pericardial cradle. A l6G cannula was sutured into the left
ventricle (LV) apex for determination of LV pressures (Pres-
sure transducer: Statham P23; natural frequency 50,4 Hz). An
l8G cannula was sutured into the proximal pulmonary artery
to facilitate the withdrawal of mixed venous (v) blood.
Two piezo-electric crystals were positioned in the LV sub-
endocardium in the minor axis of the hean; segment length
could then be measured with the aid of microsonometry
(Schuessler and Ass, USA).l Change in length of the subendo-
cardium and the LV pressure were combined on a storage
oscilloscope (Textronix 5103N, USA) to give a continuous
pressure-length (P-L) loop. Constant calibrations for the P-L
loops on the oscilloscope were used throughout the experi-
ments.
An occlusion b~oon catheter (Fogerty size 8 - l4F; Edward
Laboratories, USA) was positioned in the aona to change the
loading of the ventricle and thereby obtain the end-systolic
P-L (Ee,) relationship, which served as an index of contrac-
tility2-s (Fig. 1).
Calibrations of pressure transducers were done with a mer-
cury manometer before and during the experiments. Record-
Left
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pressure
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Fig. 1. The end-systolic pressure-length ratio (Ee,) obtained by
computer from afterload LV contractions. The slope of Ee, is a
load-independent index of myocardial contractility.
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ings were made at the end-expiratory phase and data were
stored directly on floppy disk using a microcomputer with a
mathematical microprocessor and an analogue to digital con-
verter. Sampling was done at a rate of 200 Hz for 5 seconds.
The HR was obtained from the R-R interval of the ECG.
Arterial and mixed venous blood was withdrawn into pre-
heparinised, chilled syringes and kept in ice until the determi-
nation of blood gases, haemoglobin (Hb), Hb saturation and
carboxyhaemoglobin (COHb) was performed (IL 282 Co
Oximeter; IL 613 Blood Gas Analyzer; Instrumentation
Laboratories, USA). The Severinghaus correction factors were
applied for temperature, pH and PaC02.6
The primary measurements were applied to standard haemo-
dynamic equations. Oxygen consumption was calculated as
follows:
VOz = CO. (Caoz - Cvoz), where
Caoz = 0,0139 X Hb X Hb saturation + 0,0031 X PaOz and
Cvoz = 0,0139 X Hb X Hb saturation + 0,0031 X PVoz.
COHb was taken into account in the calculations for Ca02and
CVOz.
The ratio of supply and demand was expressed as the coeffi-
cient of oxygen delivery (COD) = Ca02/(CaOZ- CVOZ).7
Data were subjected to multiple analysis of variance for
comparison between the lowest concentration used for each
anaesthetic gas (i.e. 'controls') and each subsequent measure-
ment. P < 0,05 was considered a significant difference.
Experimental design
The anaesthetic gas concentration was increased in steps as
indicated. Twenty-five minutes were allowed for stabilisation
at each new concentration before measurements were taken.
Between steps the calibrations of pressures and blood gases
were checked and corrections were made when necessary.
The anaesthetic gas concentrations evaluated were as follows:
halothane - 0,5%, 0,7%, 1,0%, 1,5%,2,0%; enflurane -0,77%,
1,2%, 1,68%,2,13%,2,57%; isoflurane - 0,77%, 1,13%, 1,52%,
1,90%,2,13%.
These concentrations were obtained by a predetermined
stepwise increase in the dial setting of the various vaporisers,
but the fmal end-expiration concentration (given above) repre-
sents the actual values as obtained from the end-tidal anaes-
thetic gas determination. Minimal alveolar concentration
(MAC) of anaesthetic values applied to data from this study
are similar to those reported by Joas er al. 8
To obtain the end-systolic pressure-length (ESPL) relation-
ship, the intra-aortic balloon was inflated over 5 - 10 beats.
The increasing end-systolic pressure and length points were
registered and the microcomputer calculined the maximum
ESPL ratio for each beat. Linear regression (least-squares
method) was performed on the data and the ESPL ratio, or
Ees, was calculated.
Results
Values in Tables I - III are the means (± SE) for the number
of experiments as indicated.
. Because the haemoglobin concentration, PaOz and Saoz did
not decrease in any of the studies, it is accepted that Caoz
remained constant during the study.
Halothane (Table I)
There was a decrease in the cardiac index (Cl) as the
halothane concentration was increased above 1,2 MAC. This
was caused by a decrease in myocardial contractility (Eo,) once
the halothane concentration was 0,89 MAC and over. Preload
remained constant and the mean arterial pressure (MAP)
decreased significantly when the haloth~e was administered
in concentrations of 1,20 MAC. The VOz did not vary and
because of the decrease in Cl, the (a - v) Doz increased
significantly if 1,72 MAC and more halothane was administered.
Enflurane (Table II)
The Cl decreased significantly when enflurane was given in
concentrations higher than 0,97 MAC. This decrease was
caused by a decrease in myocardial contractility (Eo,). The Voz
TABLE I. CARDIOVASCULAR EFFECTS OF INCREASING CONCENTRATIONS OF HALOTHANE (MEAN ± SE FOR ANIMALS)
Halothane (MAC)
HR (lmin)
MAP (mmHg)
LVEDP (mmHg)
Cl (IImin/m2)
e.. (mmHg/mm)
Pa02 (mmHg)
Sa02 (%)
Pac02 (mmHg)
pH
Hb (g/dl)
P'102 (mmHg)
5'102 (%)
Ca02 - Cv02
(ml 0 2 /100 ml
blood)
\102 (mllmin/m2)
COD
0,58
94,70±5,82
77,73±4,58
5,70±0,75
3,27±0,32
137,07± 16,58
171,90± 13,57
96,30±1,20
37,38±1,94
7,40±0,01
10,66 ± 0,44
48,08 ± 2,72
73,74±2,83
3,62±O,28
113,92 ± 8,64
4,35±O,41
0.89
95,80±3,99
75,93 ± 4,40
6,21 ±0,65
3,13 ± 0,23
105,73 ± 16,72**
168,46 ± 10,52
97,07±0,41
36,64±1,75
7,40±O,01
10,67±0,39
48,13±1,95
73,96±2,25
3,75±O,28
116,14±10,10
4,19±0,35
1.20
93,70±4,20
71,33±3,41***
6,35±O,65
2,54±O,12*
62,83± 7,83****
184,36±3,57
97,55±0,20
34,98±1,54
7,41 ±0,01
10,40±O,43
46,13±2,49
69,44±3,80
4,39±0,43
110,74± 11,17
3,62±0,35
1.72
98,50 ± 3,40
57,13±2,70***
5,60±0,84
2,00 ± 0,07**
46,27±7,26****
179,79 ± 5,91
97,53±O,21
34,33±1,29
7,42 ± 0,02
10,19 ± 0,34
44,25±2,31
65,38 ± 4,45
4,87±0,54*
97,02 ± 10,82
3,22±0,32*
2.3
97,50±3,80
42,40±2,30****
5,85±O,86
1,42± 0,07****
29,18±4,15****
178,74 ± 5,56
97,65 ± 0,20
34,65±1,31
7,41 ±O,01
10,07±0,28
41,04 ± 1,41 *
48,21 ± 5,66**
7,71 ±0,63****
101,91±10,10
2,11 ±6,17****
Statistical differences between 0,58 MAC (control values) and each subsequent concentration:
• P<O,05.
•• P< 0,01 .
••• P<0,OO5.
** .... P<O,OO1.
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TABLE 11. CARDIOVASCULAR EFFECTS OF INCREASING CONCENTRATIONS OF ENFLURANE (MEAN ± SE FOR 10 ANIMALS)
Enflurane (MAC)
HR (lmin)
MAP (mmHg)
LVEDP (mmHg)
Cl (IImin/m2)
E., (mmHg/mm)
Pa02 (mmHg)
Sa02 (%)
Pac02 (mmHg)
pH
Hb (g/dl)
Pii02 (mmHg)
Sii02 (%)
Ca02 - Cii02
(ml 0 2 /100 ml
blood)
V02 (mllmin/m2)
COD
0,35
96,00 ± 9,04
69,37±4,64
5,40±O,37
2,88 ± 0,27
142,06 ± 38,55
165,33 ± 13,70
97,84±O,14
36,82±1,34
7,39±O,02·
10,21 ±O,39
43,68±1,24
72,40±1,63
3,96 ± 0,24
114,57 ± 14,58
3,75±0,25
0,55
100,00 ± 5,92
70,40±5,92
6,03±O,68
2,47±O,30
79,31 ± 15,01
188,15±17,11
98,OO±0,17
35,46±1,52
7,40±O,Ol
10,25±O,31
45,34±1,74
73,72±1,71
3,88±O,21
95,61 ± 13,89
3,85±O,24
0,76
99,OO±7,52
66,20 ± 2,47
6,15±O,54
2,43±O,19
61,65±9,40
187,06 ± 20,43
97,80±O,46
36,32±1,40
7,40 ± 0,01
10,40±O,35
44,62±1,38
72,30±1,72
4,09±O,15
98,55 ± 7,73
3,65±0,18
0,97
99,00 ± 7,37
58,40 ± 2,40
5,44 ± 0,70
2,02±0,14**
41,65 ± 5,32*
186,46 ± 13,21 *
98,14±O,20
36,29±O,67
7,40±O,Ol
10,26±O,29
42,63± 1,66
69,55 ± 2,04
4,50±O,28
90,79 ± 7,85*
3,34±O,19
1,20
102,50 ± 6,92
51,03±2,75**
6,00 ± 0,50
1,71 ±O,10****
28,16±2,46*
201,39 ± 14,21 *
98,27±O,26
36,20±O,69
7,41 ±O,Ol
10,22±O,31
39,25 ± 1,22**
62,88±1,86
5,50±O,28****
94,11 ±7,42*
2,70±O,12****
Statisticll differences between 0,35 MAC (control values) and each subsequent concentration:
* P< 0,05.
** P< 0,01.
*** P< 0,005.
**** P < 0,001.
TABLE Ill. CARDIOVASCULAR EFFECTS OF INCREASING CONCENTRATIONS OF ISOFLURANE (MEAN ± SE FOR 10 ANIMALS)
Isoflurane (MAC)
HR (/min)
MAP (mmHg)
LVEDP (mmHg)
Cl (IImin/m2)
E., (mmHg/mm)
Pa02 (mmHg)
Sa02 (%)
Pac02 (mmHg)
pH
Hb (g/dl)
PV02 (mmHg)
Sii02 (%)
Ca02 - Cii02
(ml 0 2 /100 ml
blood)
V02 (mllmin/m2)
COD
0,52
114,00 ± 6,22
84,30±6,Ol
6,01 ±l,OO
2,87 ± 0,24
225,01 ± 100,53
159,01 ± 12,57
96,91 ±0,34
41,10±1,13
7,38±O,Ol
10,OO±O,50
45,90 ± 2,39
71,84 ± 2,33
3,17 ± 0,28
103,95 ± 5,79
3,86±O,29
0,76
114,00 ± 6,34
79,40 ± 5,28
5,80±1,12
2,73 ± 0,22
93,70 ± 17,22
164,94±7,58
97,38±O,28
38,52±1,50
7,38±O,28
10,05±0,49
44,93±2,16
71,20±2,39
3,17±O,28
103,95 ± 5,79
3,86±O,29
1,03
120,00 ± 5,57
75,OO±3,65
6,20 ± 0,83
2,68±0,19
47,69 ± 6,27*
160,59±8,74
97,25±O,34
39,13±O,97
7,38±O,Ol
9,91 ±O,46
43,95±2,25
70,22±2,48
4,03±O,29
103,17 ± 5,44
3,60±O,28
1,28
126,30 ± 4,32
66,07±4,ll**
5,39±O,96
2,38±0,20*
37,40 ± 3,67*
162,24 ± 6,07
97,29±0,40
41,80±2,74
7,40±0,01
9,59±O,39
41,63 ± 1,79*
61,15±6,53
5,OO±O,81
117,49 ± 22,80
3,10±O,32*
1,44
125,10±4,24
60,73 ± 4,29**
7,02± 1,59
2,10±0,20**
27,88 ± 2,51 *
148,14 ± 6,28
97,41 ±O,36
39,69± 1,18
7,40±O,Ol
9,40 ± 0,40
39,00 ± 1,85**
61,18±3,22**
5,15±0,57*
98,49±3,80
2,76 ± 0,22****
Statistical differences between 0,52 MAC (control values) and each subsequent concentration:
* P< 0,05.
"P<O,Ol.
*** P< 0,005.
ir*** P< 0,001.
decreased significantly once enflurane 0,97 and 1,20 MAC was
administered and the result of the Cl and V02 interaction
resulted in a decrease in COD and an increase in (a - v) D02
at 1,20 MAC enflurane.
Isoflurane (Table Ill)
The Cl was significantly decreased at 1,28 and 1,44 MAC
isoflurane. Again the decrease in myocardial contractility (Eo,)
was responsible for the reduction in flow. V02 remained
-
constant, and owing to the reduction in Cl and the stable Vo2,
the (a - v) D02 was increased when 1,28 and 1,44 MAC iso-
flurane was administered. This reduction in the O2 supply/
demand ratio is also reflected in the COD.
Discussion
An effective Cl is defmed as the blood flow that will meet
oxygen demands. 9 Apart from providing analgesia and hyp-
nosis, one of the aims of anaesthesia is to maintain aerobic
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5
Fig. 3. The coefficient of oxygen delivery (COD) starts to decrease
at approximately 1 MAC. The turning point for the COD coincides
with the MAC value at which the (a - v) DO, started to increase.
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Fig. 2. The arterial-venous oxygen difference [(a -v)Oo,l plotted
against MAC multiples for halothane, enflurane and isoflurane.
The (a -v)Oo, demonstrates an increasing tendency from approxi-
mately 1 MAC.
must look at the modifying factors of the circulation, i.e. HR
and pre- and afterload.
Clearly the isoflurane produced a higher mean HR than
enflurane or halothane. This could to some extent compensate
for the myocardial depression that followed isoflurane admini-
stration. Although halothane caused less myocardial depres-
sion, it was penalised by a slower HR and higher blood
pressure (index of afterload), while enflurane had the advan-
tage of a lower afterload that could overcome the myocardial
depression caused by increasing concentrations of the drug.
The limitations of the results from the open-ehested animal
model applied to human physiology must be kept in mind.
The MAC value at which the circulation became critical
appears to be low if one considers that higher concentration
than this is often encountered in clinical practice. A possible
explanation for this is the fact that no surgery was done during
actual experimentation and the lack of a surgical stimulus
coupled with the tight control of the Pacoz were most probably
responsible for lower cardiac· indices in our experimental
animals compared with clinical practice (especially in sponta-
neously breathing patients). However, we do believe that our
results, obtained under carefully controlled conditions, give
CaO z - CvD 2
(rnl O 2 /100 rnl
blood)
cellular oxygenation, and hence the maintenance of an effective
CO is of paramount importance. However, during anaesthesia .
the VOz usually decreases 10•11 and intuitively it is expected that
the depression of myocardial contractility associated with the
commonly used inhalational anaesthetic agents,IZ may be of
little consequence to the normal patient. Furthermore, if the
modifying factors of the circulation, i.e. the HR, preload and
afterload, changes in a favourable direction, it may well over-
come the depression of myocardial contractility caused by
halothane, enflurane and isoflurane.
The problem is to evaluate the effectiveness of the circu-
lation in terms of the definition put forward by Braunwald. 9
For this particular study we chose to use SvOz, PvOz and COD
as indices of change in cellular oxygenation. The rationale for
these parameters can be found in the Fick equation:
Voz = CO(Caoz - Cvoz) (1).
Theoretical analysis by Tenney l3 and a study by Krasnitz er
al. 14 indicate that cellular oxygen tension relates to venous
oxygen tension. Because of the relative linear shape of the
oxyhaemoglobin dissociation curve at the venous POz range, it
can, for practical purposes, be accepted that PvOz relates
direcdy to SvOz. The latter is an important component in the
calculation of Caoz. To prove the point, Krasnitz er al. 14
demonstrated that in patients with acute circulatory disorders,
a reduction in SvOz below 60% was associated with an expo-
nential increase in blood lactate concentrations and an increased
mortality.
The various factors which affect cellular oxygenation can
then be evaluated with reference to a rearranged Fick equation:
CvOz = Caoz - VOz/CO (2)
Cellular Poz= Caoz - VOz/CO (3)
Provided the Paoz remains above 8 kPa, it should not affect
the SVOZ. 15 In our experimental study the Saoz remained
above 90% (Tables I - Ill) and hence Caoz did not change
significandy. Cellular oxygenation is therefore determined by
the ratio ofVoz/CO (equation 2).
However, in order to incorporate variation in CaOz, the
relationship of.Voz to oxygen supply (Doz) can be used:
COD = DozlVoz (4)
= CO.Caoz/[CO(Caoz - CVOz)] (5)
= Caoz/(Caoz - CVOz),
where COD = coefficient of oxygen delivery7 with the normal
value = 4.
Before evaluating the data from this study, one should be
reminded of the two basic mechanisms available to the body
by which aerobic VOz can be maintained. Equation 1 predicts
that an increase in VOz could be accommodated either by an
increase in CO (and an increase in capillary density) - the
so-called vascular reserve - or by means of an increase in
(a - v) Doz, the 'metabolic' reserve. 16 The CO is the primary
buffer under non-exercise conditions and once (a - v)DOz
decreases, it signifies that the circulation is at some critical
value and hence the secondary mechanism must be employed.
Results from this study indicate that the COD and (a - v)
Doz started to change at approximately similar MAC values
(Figs 2 and 3). Although statistical analysis was not applied to
verify this, Figs 1 and 2 demonstrate tendencies that support
this concept. Because equipotent concentrations of the inhala-
tional agents were not used, statistical comparisons between
the gases were not attempted.
The CO is a function of HR and SV. SV is again deter-
mined by preload, afterload and contractility. Detailed analysis
of the effect of the three drugs on myocardial contractility has
been published elsewhere. 1z We have demonstrated that halo-
thane caused the least myocardial depression and there is little
difference between enflurane and isoflurane, although both
were associated with more myocardial depression than halo-
thane. Given this fact, why would the circulation become
'critical' at similar MAC values? To answer the question one
-valuable insight into oxygen delivery during inhalational anaes-
thesia.
If the effect on the circulation appears to be of equal
magnitude (with reference to cellular oxygenation), the indica-
tions for use in everyday clinical practice can be discussed. In
the patient with normal myocardial reserve, it is probably
immaterial which drug is used. The deciding factor will in
these cases probably relate to cost and availability. In the
patient with poor systolic reserve of the myocardium, i.e.
either overt failure or a history of myocardial failure, the drug
with the least myocardial depression, i.e. halothane, is prefer-
able. However, the maintenance of the MAP with halothane
may be detrimental to the SV, and the use of other anaesthetic
drugs that cause a slight reduction in MAP will be of obvious
benefit. Drugs like opiates and droperidol will be useful (in
small doses) and the direct vasodilators will also assist the
ejection of the SV in the heart with depressed function.
The patient with ischaemic heart disease requires a slower
HR and maintenance of diastolic arterial pressure. Halothane
seems to be the agent of choice, while enflurane, with its
associated decrease in MAP, should not be the primary choice.
Isoflurane, apart from the fact that it can induce coronary
'steal',l? is also responsible for a tachycardia. The latter, in the
non-failing heart, will limit oxygen supply to the myocardium
due to the decrease in diastolic time. IS In the failing heart,
which dilates if subjected to an increase in HR, it will cause an
increase in myocardial tension and therefore oxygen consump-
tion and, coupled with the limited diastolic period for perfusion
to the LV, can precipitate cellular hypoxia.
Clinical evaluation of the patient with reference to congestive
symptoms, exercise tolerance or, if available, more invasive
measurements, coupled with the basic physiology of the circu-
lation as discussed, may serve to ensure the rational use of the
three available potent inhalational anaesthetic vapours.
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